My response back…

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

My response back…

posted on Oct 31, 2023 02:17PM

"This is an insane response. Don’t be selective then , tell your shareholders & the entire market just what the heck is going on. I’m sure you can understand & appreciate how these sorts of responses just irritate all.Theres little to no patience left with either of these companies along with the mushroom/in the dark unhelpful responses Chris. Hopefully it’s made crystal clear one of these years!